Retrospective Study of the Etiology and Risk Factors of Systemic Inflammatory Response Syndrome After Systematic Transrectal Ultrasound-Guided Prostate Biopsy

被引:4
作者
Lei, Huang [1 ]
Dong, Xingyou [1 ]
Li, Longkun [1 ]
Huan, Feng [1 ]
Zhong, Xiao [1 ]
Wu, Qingjian [1 ]
Fang, He [1 ]
Zhang, Teng [1 ]
Yang, Xinliang [1 ]
Zhu, Jingzhen [1 ]
Li, Jia [1 ]
Jiang, Zhao [1 ]
机构
[1] Army Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing 400037, Peoples R China
基金
中国国家自然科学基金;
关键词
systematic transrectal ultrasound-guided prostate biopsy; systemic inflammatory response syndrome; prostate cancer; risk factors infection; pathogens; ERYTHROCYTE SEDIMENTATION-RATE; INFECTIOUS COMPLICATIONS; CANCER DETECTION; POPULATION; PREVENTION; PREVALENCE; DISEASE; RATES;
D O I
10.2147/IDR.S256548
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To explore the risk factors, pathogenic bacteria distribution and drug resistance of systematic transrectal ultrasound-guided prostate biopsy (TRUS-Bx), 329 cases of TRUS-Bx were collected, retrospectively, in the Second Affiliated Hospital, Army Military Medical University, from April 2017 to October 2019. Methods: A total of 329 cases were all qualified and grouped into the SIRS group (25 cases) and the non-SIRS group (304 cases). Of all the cases, incidence and risk factors of systemic inflammatory response syndrome (SIRS) were analyzed. Urine and blood samples of patients with SIRS after TRUS-Bx were also collected for bacterial culture and drug sensitivity test. Results: Multivariate logistic regression analysis showed that BMI >= 25 kg/m(2) (OR = 1.66, 95% CI = 1.34-2.12, P < 0.001), history of diabetes (OR = 5.48, 95% CI = 1.53-19.68, P = 0.008), urinary infection before operation (OR = 9.19, 95% CI = 2.92-20.93, P < 0.001) and erythrocyte sedimentation (ESR) >= 20 mm/h (OR = 1.04, 95% CI = 1.01-1.08, P = 0.039) were independent risk factors of SIRS after TURS-PB. Conclusion: The incidence of SIRS and urinary sepsis was 7.59% and 2.13%, respectively, and major pathogens of SIRS after TRUS-Bx were Escherichia coli (58.33%), Klebsiella pneumoniae (12.5%) and Pseudomonas aeruginosa (12.5%). Imipenem, meropenem, tigecycline, piperacillin/tazobactam, teicoplanin, vancomycin, amikacin and cefoperazone/sulbactam had a very strong inhibitory effect to those pathogenic bacteria (sensitivity 85.72%similar to 100%). Levofloxacin, ciprofloxacin, gentamicin, penicillin G, compound neonomine and second-generation cephalosporins showed less but also worked as a good inhibitor to pathogenic bacteria (42.86%similar to 80.95%). Keywords: systematic transrectal ultrasound-guided prostate biopsy, systemic inflammatory response syndrome, prostate cancer, risk factors infection, pathogens
引用
收藏
页码:3187 / 3193
页数:7
相关论文
共 32 条
[1]   The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones [J].
AlKhateeb, Sultan S. ;
AlShammari, Nayf A. ;
AlZughaibi, Mohand A. ;
Ghazwani, Yahya G. ;
Alrabeeah, Khalid A. ;
Albqami, Nasser M. .
SAUDI MEDICAL JOURNAL, 2016, 37 (08) :860-863
[2]   Increasing Risk of Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsies: Time to Reassess Antimicrobial Prophylaxis? [J].
Carignan, Alex ;
Roussy, Jean-Francois ;
Lapointe, Veronique ;
Valiquette, Louis ;
Sabbagh, Robert ;
Pepin, Jacques .
EUROPEAN UROLOGY, 2012, 62 (03) :453-459
[3]   International Variation in Prostate Cancer Incidence and Mortality Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Lortet-Tieulent, Joannie ;
Ward, Elizabeth ;
Ferlay, Jacques ;
Brawley, Otis ;
Bray, Freddie .
EUROPEAN UROLOGY, 2012, 61 (06) :1079-1092
[4]   High-risk prostate cancer-classification and therapy [J].
Chang, Albert J. ;
Autio, Karen A. ;
Roach, Mack, III ;
Scher, Howard I. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (06) :308-323
[5]   The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review [J].
Cussans, Amelia ;
Somani, Bhaskar K. ;
Basarab, Adriana ;
Dudderidge, Timothy J. .
BJU INTERNATIONAL, 2016, 117 (05) :725-731
[6]   Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review [J].
Endzelins, Edgars ;
Melne, Vita ;
Kalnina, Zane ;
Lietuvietis, Vilnis ;
Riekstina, Una ;
Llorente, Alicia ;
Line, Aija .
MOLECULAR CANCER, 2016, 15
[7]   Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora [J].
Eruz, Emine Dilek ;
Yalci, Aysun ;
Ozden, Eriz ;
Aslaner, Halide ;
Durgun, Suna Ogucu ;
Taymur, Deniz Derya ;
Memikoglu, Kemal Osman ;
Erdem, Hakan ;
Kurt, Halil .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2017, 11 (02) :188-191
[8]   Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy [J].
Han, Misop ;
Chang, Doyoung ;
Kim, Chunwoo ;
Lee, Brian J. ;
Zuo, Yihe ;
Kim, Hyung-Joo ;
Petrisor, Doru ;
Trock, Bruce ;
Partin, Alan W. ;
Rodriguez, Ronald ;
Carter, H. Ballentine ;
Allaf, Mohamad ;
Kim, Jongwon ;
Stoianovici, Dan .
JOURNAL OF UROLOGY, 2012, 188 (06) :2404-2409
[9]   Is an Initial Saturation Prostate Biopsy Scheme Better than an Extended Scheme for Detection of Prostate Cancer? A Systematic Review and Meta-analysis [J].
Jiang, Xingkang ;
Zhu, Shimiao ;
Feng, Guowei ;
Zhang, Zhihong ;
Li, Changying ;
Li, Hui ;
Wang, Chao ;
Xu, Yong .
EUROPEAN UROLOGY, 2013, 63 (06) :1031-1039
[10]   Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy [J].
Kalkanli, Arif ;
Gezmis, Cem Tugrul ;
Ozkan, Arif ;
Cilesiz, Nusret Can ;
Yanaral, Fatih ;
Aydin, Memduh ;
Tandogdu, Zafer .
BALKAN MEDICAL JOURNAL, 2018, 35 (05) :373-377